Release Date: 04/06/19 10:30 Summary: Resources Rising Stars Investor Presentation Price Sensitive: Yes Download Document 2.88MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%